- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04124380
Understanding and Testing Recovery Processes for PTSD and Alcohol Use Following Sexual Assault
March 25, 2024 updated by: Michele Bedard-Gilligan, University of Washington
Sexual assault can lead to devastating consequences including the development of chronic conditions including posttraumatic stress disorder (PTSD) and alcohol use disorders (AUD).
Interventions delivered soon after exposure to assault can decrease the long-term negative consequences of sexual assault but existing interventions are limited in their ability to target concurrent PTSD symptoms and alcohol use and little is known about how to make best practice treatment decisions in the early period following sexual assault.
A greater emphasis on transdiagnostic processes that are related to both PTSD and alcohol use, such as fear and reward systems, can elucidate mechanisms of recovery, lead to the development of more effective intervention approaches, and guide clinical decision making for patients recently exposed to sexual assault.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Following sexual assault, many individuals will develop chronic problems including posttraumatic stress disorder (PTSD) and alcohol use disorders (AUD).
Intervention provided soon after assault can decrease the risk of developing chronic psychopathology and associated negative consequences.
Interventions that address common underlying mechanisms of PTSD and alcohol use, such as fear and reward systems, have strong potential utility as efficacious and accessible interventions for clinicians treating patients recently exposed to sexual assault.
This proposal is designed to test fear and reward as crucial processes underlying recovery following sexual assault and elucidate the most efficacious treatment targets.
Employing experimental tasks (safety-signal learning paradigm and probabilistic reward task) to capture baseline underlying vulnerabilities in fear and reward systems respectively will allow for exploration of how these processes impact recovery.
A randomized clinical trial (N = 180) will be conducted to test efficacy of intervention approaches that target PTSD or alcohol use compared to supportive telehealth.
In addition, a phased study design will allow for exploration of efficacy of primary and secondary intervention approaches to test the questions of 1) whether it is more efficacious to target PTSD or alcohol use first; and 2) whether it is necessary to target both PTSD and alcohol use to facilitate recovery or if one is sufficient.
This proposal is significant in exploring transdiagnostic mechanisms implicated in recovery following sexual assault, fear and reward, and using a novel design to compare efficacy, ordering, and necessity of two distinct intervention approaches.
Study Type
Interventional
Enrollment (Estimated)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Michele Bedard-Gilligan, PhD
- Phone Number: 206-616-4215
- Email: mab29@uw.edu
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98105
- Recruiting
- University of Washington
-
Contact:
- Michele A Bedard-Gilligan, PhD
- Phone Number: 206-685-3617
-
Principal Investigator:
- Michele A Bedard-Gilligan, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Identifies as female.
- Between the age of 18 and 65.
- Reports a sexual assault in the last 4 weeks to 1 year.
- Current PTSD severity of 23+ on the PSS-I-5.
- Current heavy alcohol use (2+ heavy episodic drinking occasions [4+ drinks on one occasion] in past month).
- Access to the internet and a device with a webcam.
Exclusion Criteria:
- Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by the DSM-5.
- Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
- Unwilling or unable to discontinue current trauma-focused psychotherapy or current substance use psychotherapy.
- Unstable dose of psychotropic medications in the prior 3 months.
- Ongoing intimate relationship with the perpetrator of most recent assault.
- Current diagnosis of a severe substance use disorder according to DSM-5, other than alcohol in the last month.
- No clear trauma memory.
- Current higher dose use of benzodiazepines (greater than the equivalent of 4 mg of lorazepam, 2 mg alprazolam, 1.5 mg clonazepam, or 20 mg of diazepam).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Imaginal Exposure First, then Alcohol Skills
Imaginal exposure to the sexual assault memory targeting PTSD symptoms after sexual assault.
After imaginal exposure, alcohol skills targeting alcohol misuse after sexual assault.
|
Six 50 min, twice weekly video telehealth sessions will be provided based on prolonged exposure therapy for PTSD.
This brief intervention includes psycho-education and focuses on imaginal exposure only based on Zoellner et al., (2016).
Six 50 min, twice weekly video telehealth sessions will be provided based on content from the alcohol skills training program and CBT protocols.
Each session includes teaching skills and practice, focusing on mitigating rewarding aspects of alcohol, addressing cravings, and increasing other natural rewards.
|
Experimental: Alcohol Skills First, then Imaginal Exposure
Alcohol skills targeting alcohol misuse after sexual assault.
After alcohol skills training, imaginal exposure to the sexual assault memory targeting PTSD symptoms after sexual assault.
|
Six 50 min, twice weekly video telehealth sessions will be provided based on prolonged exposure therapy for PTSD.
This brief intervention includes psycho-education and focuses on imaginal exposure only based on Zoellner et al., (2016).
Six 50 min, twice weekly video telehealth sessions will be provided based on content from the alcohol skills training program and CBT protocols.
Each session includes teaching skills and practice, focusing on mitigating rewarding aspects of alcohol, addressing cravings, and increasing other natural rewards.
|
Active Comparator: Supportive Counseling/Telehealth
Internet-based intervention focusing on providing support.
|
The supportive counseling intervention, modeled after Litz et al. (2007), will ask participants to self-monitor their experience of weekly symptoms and complete weekly online writing about daily non-trauma related concerns and hassles.
Participants will talk with a therapist on the telephone twice per week.
|
Experimental: Alcohol Skills First, no additional treatment
Alcohol skills targeting alcohol misuse after sexual assault only.
No additional treatment.
|
Six 50 min, twice weekly video telehealth sessions will be provided based on content from the alcohol skills training program and CBT protocols.
Each session includes teaching skills and practice, focusing on mitigating rewarding aspects of alcohol, addressing cravings, and increasing other natural rewards.
|
Experimental: Imaginal Exposure First, no additional treatment
Imaginal exposure to the sexual assault memory targeting PTSD symptoms after sexual assault.
No additional treatment.
|
Six 50 min, twice weekly video telehealth sessions will be provided based on prolonged exposure therapy for PTSD.
This brief intervention includes psycho-education and focuses on imaginal exposure only based on Zoellner et al., (2016).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol Use Interview
Time Frame: Past month
|
Alcohol use will be measured using the Timeline Followback Interview (TLFB) to measure frequency and quantity of drinking behavior over the past month.
The TLFB is a count of total drinks per day over the last month.
Higher number of drinks on the TLFB represents higher alcohol use and worse outcomes.
|
Past month
|
Alcohol Use Self-Report
Time Frame: Past month
|
Alcohol use will be measured using the Daily Drinking Questionnaire (DDQ) to assess for self report of typical weekly drinking (quantity, frequency).
The DDQ asks for an estimated number of drinks consumed on each day in a typical week over the last month.
Higher estimates for number of typical drinks each day on the DDQ represents higher alcohol use and worse outcomes.
|
Past month
|
Posttraumatic Stress Disorder Severity (PTSD) Interview
Time Frame: Past two weeks
|
PTSD symptom severity will be measured using the Posttraumatic Stress Symptoms Scale- Interview Version for DSM-5 (PSS-I-5).
The PSS-I-5 is a 20 item scale, with a minimum score of 0 and a maximum score of 80; higher values represent increased PTSD symptom severity and worse outcomes.
|
Past two weeks
|
Posttraumatic Stress Disorder Severity (PTSD) Self-Report
Time Frame: Past two weeks
|
PTSD symptom severity will be measured using the Posttraumatic Stress Symptoms Scale- Self-report Version for DSM-5 (PSS-SR-5).
The PSS-SR-5 is a 20 item scale, with a minimum score of 0 and a maximum score of 80; higher values represent increased PTSD symptom severity and worse outcomes.
|
Past two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychosocial Functioning
Time Frame: Past two weeks
|
The single-item Global Psychosocial Functioning (GPF) item will be used as an indicator of functioning.
The GPF will be reworded so as to be disorder non-specific.
It is rated on a scale from 0 - 100 with higher scores representing better outcomes.
|
Past two weeks
|
Quality of Life Functioning
Time Frame: Past two weeks
|
The single-item Global Quality of Life (GQL) item will be used as an indicator of functioning.
It is rated on a scale from 0 - 100 with higher scores representing better outcomes.
|
Past two weeks
|
Alcohol Cravings
Time Frame: Past week
|
The 5-item Penn Alcohol Craving Scale (PACS) will be given to assess current urges and cravings to drink alcohol.
Items assess frequency, intensity, and duration of thoughts about drinking and participants rate their perceived ability to resist drinking.
Total sum score on this measure ranges from 0 to 30.
Higher scores represent more alcohol cravings and worse outcomes.
|
Past week
|
Alcohol Consequences
Time Frame: Past week
|
The Short Inventory of Problems (SIP) will be given to assess alcohol related negative consequences.
The SIP is a 15 item scale, with 3 items per subscale.
This measure was adapted to use a time frame of the past week for responses.
This measure has a minimum score of 0 and a maximum score of 15.
Higher values represent increased alcohol-related problems and worse outcomes.
|
Past week
|
Depression Self-Report
Time Frame: Past week
|
Depression will be measured with the Quick Inventory of Depressive Symptoms (QIDS-SR16) self report version.
The QIDS-SR16 is a 16 item scale, with a minimum score of 0 and a maximum score of 48; higher values represent increased depression and worse outcomes.
|
Past week
|
Depression Interview
Time Frame: Past week
|
Depression will be measured with the Quick Inventory of Depressive Symptoms (QIDS-C16) interview version.
The QIDS-C16 is a 16 item scale, with a minimum score of 0 and a maximum score of 27; higher values represent increased depression and worse outcomes.
|
Past week
|
Reward
Time Frame: Past week
|
Reward functioning will be measured with the Snaith-Hamilton Pleasure Scale (SHAPS), self-report.
The SHAPS is a 14 item scale, with a minimum score of 0 and a maximum score of 14; higher values represent increased anhedonia and worse outcomes.
|
Past week
|
Fear
Time Frame: Past week
|
Fear will be measured with the Posttrauma Avoidance Behavior Questionnaire (PABQ), self-report.
The PABQ is a 25 item scale, with a minimum score of 25 and a maximum score of 100; higher values represent increased fear and worse outcomes.
|
Past week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michele Bedard-Gilligan, PhD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2021
Primary Completion (Estimated)
June 1, 2025
Study Completion (Estimated)
August 31, 2025
Study Registration Dates
First Submitted
September 23, 2019
First Submitted That Met QC Criteria
October 9, 2019
First Posted (Actual)
October 11, 2019
Study Record Updates
Last Update Posted (Actual)
March 27, 2024
Last Update Submitted That Met QC Criteria
March 25, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00008021
- R01AA027499 (U.S. NIH Grant/Contract)
- 1F32AA029865-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
-
Yale UniversityNational Center for PTSDCompletedPosttraumatic Stress Disorder (PTSD)United States
Clinical Trials on Imaginal Exposure
-
University of LouisvilleCompletedAnorexia Nervosa | Bulimia Nervosa | Eating Disorder | ExposureUnited States
-
Uppsala UniversityCompletedIndividuals With Fear of SpidersSweden
-
University of LouisvilleCompletedAnorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa | Therapy | Eating Disorder | ExposureUnited States
-
University of WashingtonNational Institute on Drug Abuse (NIDA)CompletedMarijuana Abuse | Chronic Post-Traumatic Stress DisorderUnited States
-
University of WaterlooUniversity of Toronto; Hebrew University of Jerusalem; BaycrestCompleted
-
Medical University of South CarolinaRalph H. Johnson VA Medical CenterWithdrawnPosttraumatic Stress Disorder
-
Palo Alto Veterans Institute for ResearchCompletedWritten Exposure Therapy | Imaginal Exposure TherapyUnited States
-
Emory UniversityCenters for Disease Control and PreventionWithdrawnPost Traumatic Stress Disorder, PTSD
-
Hebrew University of JerusalemRecruitingSocial Anxiety | Generalized Anxiety | Panic | Obsessive-Compulsive SymptomIsrael
-
Uppsala UniversityRecruiting